A preliminary trial of ascorbic acid as supplemental therapy for autism
- 1 September 1993
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 17 (5) , 765-774
- https://doi.org/10.1016/0278-5846(93)90058-z
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five YearsJournal of the American Academy of Child & Adolescent Psychiatry, 1988
- Nutrition and Developmental DisabilitiesPublished by Springer Nature ,1987
- A Scale for Rating Symptoms of Patients with the Syndrome of Autism in Real Life SettingsJournal of the American Academy of Child Psychiatry, 1986
- Modulation of neostriatal activity by iontophoresis of ascorbic acidBrain Research, 1985
- Ascorbic Acid and the Behavioral Response to Haloperidol: Implications for the Action of Antipsychotic DrugsScience, 1985
- Ascorbic acid could be hazardous to your experiments: A commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal functionNeuropharmacology, 1983
- Studies on the stability of 3H-dopamine in neostriatal membrane preparations: Effects of ascorbic acidLife Sciences, 1983
- Ascorbic acid and the binding of DA agonists to neostriatal membrane preparationsNeuropharmacology, 1983
- Pharmacology of [3H]apomorphine binding to bovine brain tissueBiochemical Pharmacology, 1981
- Inhibition of dopamine D-1 and D-2 binding sites in neuronal tissue by ascorbateNeuropharmacology, 1981